|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses | |||||
| General and administrative | |||||
| Research and development | |||||
| Sales and marketing | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other expense, net | |||||
| Change in fair value of derivative instruments | |||||
| Change in fair value of earn-out shares liability | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Change in net unrealized gain (loss), net of tax of $0, for the years ended December 31, 2024 and 2023 | |||||
| Total comprehensive loss | |||||
| Net loss per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollar per share) | |||||
| Weighted average shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...